Failure To Cite Business Relationship To Applicant In Declaration To PTO Results In Finding Of Inequitable Conduct
Client Alert | 1 min read | 02.21.06
In Ferring B.V. & Aventis Pharms., Inc. v. Barr Labs, Inc. (No. 05-1284; Feb. 15, 2006), the Federal Circuit affirms the district court's summary judgment of unenforceability due to inequitable conduct. Writing for the majority, Judge Dyk holds that four allegedly disinterested declarations submitted to the PTO by individuals who had an unstated business relationship with the applicant provide sufficient evidence of materiality and intent to deceive even under the higher evidentiary standards of summary judgment.
U.S. Pat. No. 5,407,398 was initially rejected during prosecution as anticipated by another U.S. patent. In an effort to overcome the rejection, the applicant submitted a number of declarations from supposedly disinterested parties to provide “objective evidence” regarding the definition of a key claim term. Based in part upon those declarations the examiner allowed the patent. Trial testimony later revealed a prior business relationship with four of the five declarants. The majority agreed with the district court that these omissions were highly material and made with intent to deceive. Judge Newman points out in her lengthy dissent that the court's finding of intent to deceive was based entirely upon failure to list the business relationship in each declarant's CV, where one would not normally include such information. Judge Newman also took issue with the fact that inequitable conduct was found here on summary judgment and concludes that the majority not only ignored Kingsdown but also creates a new “‘should have known' standard of materiality, from which deceptive intent is inferred, even in the total absence of evidence.”
Insights
Client Alert | 3 min read | 09.08.25
RADV Audits: Implications and Recommendations for Medicare Advantage Organizations
CMS is well underway in initiating and conducting its Risk Adjustment Data Validation (RADV) audits of Medicare Advantage (MA) organizations for PY 2019, and PY 2020 audit notices are likely to arrive by the end of September. The timing for subsequent PY audits is less clear, but notices will likely be coming soon given CMS’s announced plans to complete all remaining audits by early 2026, including all contracts for PY 2020 and beyond. This approach marks a significant deviation from the agency’s prior policy of reviewing only a fraction of contracts and at a much slower pace.
Client Alert | 3 min read | 09.04.25
Client Alert | 2 min read | 09.03.25
Client Alert | 5 min read | 09.03.25
If You’re Not First, You’re Last: Federal Circuit’s First Review of an AIA Derivation Proceeding